|
Volume
7 Number 11
November 2019
|
|
Home
>
Disciplines
>
Publications
>
Prostate
Cancer
Reviews
>
Volume
7, Year 2019 >
Number 11, November
|
|
|
CONTENTS
|
▼
|
|
DIAGNOSIS
EPIDEMIOLOGY,
RISK FACTORS, PREVENTION
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
FOLLOW-UP,
SIDE EFFECTS, QUALITY OF LIFE
INTEGRATIVE
MEDICINE
OVERALL
MANAGEMENT
PROGNOSIS
TREATMENT
|
|
|
DIAGNOSIS
|
▲
|
|
Chatterjee A, Thomas S, Oto A.
Prostate MR: pitfalls and
benign lesions.
Abdom Radiol (NY). 2019 Nov 8. doi:
10.1007/s00261-019-02302-x. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Duffy MJ.
Biomarkers for prostate cancer:
prostate-specific antigen and beyond.
Clin Chem Lab Med.
2019 Nov 12. doi: 10.1515/cclm-2019-0693. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Engels RRM, Israël B, Padhani AR, Barentsz JO.
Multiparametric Magnetic Resonance Imaging for the
Detection of Clinically Significant Prostate Cancer: What
Urologists Need to Know. Part 1: Acquisition.
Eur Urol.
2019 Sep 30. doi: 10.1016/j.eururo.2019.09.021. [Epub ahead of
print]
Source
.
Similar
articles
|
|
|
|
Elsherif SB, Kuchana V, Aslam R, Kamat A, Bhosale PR, Klekers AR.
Locally advanced prostate cancer imaging findings and
implications for treatment from the surgical perspective.
Abdom Radiol (NY). 2019 Nov 13. doi:
10.1007/s00261-019-02318-3. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Henry A.
Using Multiparametric Magnetic Resonance Imaging
to Shift Prostate Cancer Diagnosis Toward Clinically Significant
Disease and Minimize Overdiagnosis (and Overtreatment).
Int
J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):915-917. doi:
10.1016/j.ijrobp.2019.09.040.
Source
.
Similar
articles
|
|
|
|
Israël B, Leest MV, Sedelaar M, Padhani AR, Zámecnik
P, Barentsz JO.
Multiparametric Magnetic Resonance
Imaging for the Detection of Clinically Significant Prostate
Cancer: What Urologists Need to Know. Part 2: Interpretation.
Eur Urol. 2019 Nov 23. doi: 10.1016/j.eururo.2019.10.024.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Luiting HB, van Leeuwen PJ, Busstra MB, Brabander T, van der Poel
HG, Donswijk ML, Vis AN, Emmett L, Stricker PD, Roobol MJ.
Use
of gallium-68 prostate-specific membrane antigen positron-emission
tomography for detecting lymph node metastases in primary and
recurrent prostate cancer and location of recurrence after radical
prostatectomy: an overview of the current literature.
BJU
Int. 2019 Nov 4. doi: 10.1111/bju.14944. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Mussi TC, Baroni RH, Zagoria RJ, Westphalen AC.
Prostate
magnetic resonance imaging technique.
Abdom Radiol (NY).
2019 Nov 7. doi: 10.1007/s00261-019-02308-5. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Nevo A, Navaratnam A, Andrews P.
Prostate cancer and the
role of biomarkers.
Abdom Radiol (NY). 2019 Nov 13. doi:
10.1007/s00261-019-02305-8. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Venderink W, Bomers JG, Overduin CG, Padhani AR, de Lauw GR,
Sedelaar MJ, Barentsz JO.
Multiparametric Magnetic
Resonance Imaging for the Detection of Clinically Significant
Prostate Cancer: What Urologists Need to Know. Part 3: Targeted
Biopsy.
Eur Urol. 2019 Nov 29. doi:
10.1016/j.eururo.2019.10.009. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
EPIDEMIOLOGY,
RISK FACTORS, PREVENTION
|
▲
|
|
Heidegger I, Tsaur I, Borgmann H, Surcel C, Kretschmer A, Mathieu
R, Visschere P, Valerio M, van den Bergh RCN, Ost P, Tilki D,
Gandaglia G, Ploussard G; EAU-YAU Prostate Cancer Working Party.
Hereditary prostate cancer - Primetime for genetic
testing?
Cancer Treat Rev. 2019 Dec;81:101927. doi:
10.1016/j.ctrv.2019.101927. Epub 2019 Nov 11.
Source
.
Similar
articles
|
|
|
|
Tharakan T, Bettocchi C, Carvalho J, Corona G, Joensen UN, Jones
H, Kadioglu A, Martínez Salamanca JI, Serefoglu EC, Verze
P, Darraugh J, Plass K, N'Dow J, Salonia A, Minhas S; EAU Working
Group on Male Sexual and Reproductive Health.
Male Sexual
and Reproductive Health-Does the Urologist Have a Role in
Addressing Gender Inequality in Life Expectancy?
Eur
Urol Focus. 2019 Nov 8. doi: 10.1016/j.euf.2019.10.009. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
|
▲
|
|
O'Shea A, Kilcoyne A, Hedgire SS, Harisinghani MG.
Pelvic
lymph nodes and pathways of disease spread in male pelvic
malignancies.
Abdom Radiol (NY). 2019 Oct 31. doi:
10.1007/s00261-019-02285-9. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
FOLLOW-UP,
SIDE EFFECTS, QUALITY OF LIFE
|
▲
|
|
Ballon-Landa E, Panian J, Derweesh IH, McKay RR.
Management
of bone complications in patients with genitourinary malignancies.
Urol Oncol. 2019 Oct 29. doi: 10.1016/j.urolonc.2019.09.028.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
El Badri SAM, Salawu A, Brown JE.
Bone Health in Men with
Prostate Cancer: Review Article.
Curr Osteoporos Rep.
2019 Dec;17(6):527-537. doi: 10.1007/s11914-019-00536-8.
Source
.
Similar
articles
|
|
|
|
Hebenstreit D, Pichler R, Heidegger I.
Drug-Drug
Interactions in Prostate Cancer Treatment.
Clin
Genitourin Cancer. 2019 May 27. doi: 10.1016/j.clgc.2019.05.016.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Liang Z, Zhu J, Chen L, Xu Y, Yang Y, Hu R, Zhang W, Song Y, Lu Y,
Ou N, Liu X.
Is androgen deprivation therapy for prostate
cancer associated with cardiovascular disease? A meta-analysis and
systematic review.
Andrology. 2019 Nov 19. doi:
10.1111/andr.12731. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Liu R, Zhou J, Xia S, Li T.
Androgen Deprivation Therapy
and the Risk of Stroke in Patients with Prostate Cancer: An
Updated Systematic Review and Meta-Analysis.
Urol Int.
2019 Nov 20:1-8. doi: 10.1159/000503906. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
INTEGRATIVE
MEDICINE
|
▲
|
|
Kis B, Ifrim FC, Buda V, Avram S, Pavel IZ, Antal D, Paunescu V,
Dehelean CA, Ardelean F, Diaconeasa Z, Soica C, Danciu C.
Cannabidiol-from Plant to Human Body: A Promising
Bioactive Molecule with Multi-Target Effects in Cancer.
Int
J Mol Sci. 2019 Nov 25;20(23). pii: E5905. doi:
10.3390/ijms20235905.
Source
.
Similar
articles
|
|
|
|
Lai SW, Kuo YH, Liao KF.
Statins use and prostate cancer
mortality.
Eur J Cancer. 2020 Jan;124:219-220. doi:
10.1016/j.ejca.2019.09.017. Epub 2019 Oct 31.
Source
.
Similar
articles
|
|
|
|
Reglero C, Reglero G.
Precision Nutrition and Cancer
Relapse Prevention: A Systematic Literature Review.
Nutrients. 2019 Nov 16;11(11). pii: E2799. doi:
10.3390/nu11112799.
Source
.
Similar
articles
|
|
|
OVERALL
MANAGEMENT
|
▲
|
|
Ghadjar P, Fiorino C, Munck Af Rosenschöld P, Pinkawa M,
Zilli T, van der Heide UA.
ESTRO ACROP consensus
guideline on the use of image guided radiation therapy for
localized prostate cancer.
Radiother Oncol. 2019
Dec;141:5-13. doi: 10.1016/j.radonc.2019.08.027. Epub 2019 Oct 23.
Source
.
Similar
articles
|
|
|
|
Hess-Busch Y, Hadaschik B, Hess J.
M0CRPC overview of
management options.
World J Urol. 2019 Nov 5. doi:
10.1007/s00345-019-02997-z. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Saad F, Canil C, Finelli A, Hotte SJ, Malone S, Shayegan B, So AI,
Aaron L, Basappa NS, Conter HJ, Danielson B, Gotto G, Hamilton RJ,
Izard JP, Kapoor A, Kolinsky M, Lalani AA, Lattouf JB, Morash C,
Morgan SC, Niazi T, Noonan KL, Ong M, Rendon RA, Sehdev S, Hew H,
Park-Wyllie L, Chi KN.
A Canadian consensus forum on the
management of patients with advanced prostate cancer.
Can
Urol Assoc J. 2019 Nov 5. doi: 10.5489/cuaj.6082. [Epub ahead of
print]
Source
.
Similar
articles
|
|
|
PROGNOSIS
|
▲
|
|
Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, Wang
X, Pugh SE, Sandler KA, Bolla M, Maingon P, De Reijke T, Nickols
NG, Rettig M, Drakaki A, Liu ST, Reiter RE, Chang AJ, Feng FY,
Sajed D, Nguyen PL, Kupelian PA, Steinberg ML, Boutros PC,
Elashoff D, Collette L, Sandler HM.
Local Failure and
Survival After Definitive Radiotherapy for Aggressive Prostate
Cancer: An Individual Patient-level Meta-analysis of Six
Randomized Trials.
Eur Urol. 2019 Nov 10. doi:
10.1016/j.eururo.2019.10.008. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Su S, Liu L, Li C, Zhang J, Li S.
Prognostic role of
pretreatment derived neutrophil to lymphocyte ratio in urological
cancers: A systematic review and meta-analysis.
Int J
Surg. 2019 Dec;72:146-153. doi: 10.1016/j.ijsu.2019.10.043. Epub
2019 Nov 9.
Source
.
Similar
articles
|
|
|
|
Tao R, Dai J, Bai Y, Yang J, Sun G, Zhang X, Zhao J, Zeng H, Shen
P.
The prognosis benefits of adjuvant versus salvage
radiotherapy for patients after radical prostatectomy with adverse
pathological features: a systematic review and meta-analysis.
Radiat Oncol. 2019 Nov 9;14(1):197. doi:
10.1186/s13014-019-1384-z.
Source
.
Similar
articles
|
|
|
TREATMENT
|
▲
|
|
Blazevski A, Scheltema MJ, Amin A, Thompson JE, Lawrentschuk N,
Stricker PD.
Irreversible electroporation (IRE): a
narrative review of the development of IRE from the laboratory to
a prostate cancer treatment.
BJU Int. 2019 Nov 14. doi:
10.1111/bju.14951. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Cetin B, Ozet A.
The Potential for Chemotherapy-Free
Strategies in Advanced Prostate Cancer.
Curr Urol. 2019
Oct;13(2):57-63. doi: 10.1159/000499292. Epub 2019 Oct 1.
Source
.
Similar
articles
|
|
|
|
Connor MJ, Shah TT, Horan G, Bevan CL, Winkler M, Ahmed HU.
Cytoreductive treatment strategies for de novo metastatic
prostate cancer.
Nat Rev Clin Oncol. 2019 Nov 11. doi:
10.1038/s41571-019-0284-3. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Dell'Oglio P, Mottrie A, Mazzone E.
Robot-assisted
radical prostatectomy vs. open radical prostatectomy: latest
evidences on perioperative, functional and oncological outcomes.
Curr Opin Urol. 2020 Jan;30(1):73-78. doi:
10.1097/MOU.0000000000000688.
Source
.
Similar
articles
|
|
|
|
Heidenreich A, Pfister D.
Radical cytoreductive
prostatectomy in men with prostate cancer and oligometastatic
disease.
Curr Opin Urol. 2020 Jan;30(1):90-97. doi:
10.1097/MOU.0000000000000691.
Source
.
Similar
articles
|
|
|
|
Kamran SC, D'Amico AV.
Radiation Therapy for Prostate
Cancer.
Hematol Oncol Clin North Am. 2020
Feb;34(1):45-69. doi: 10.1016/j.hoc.2019.08.017. Epub 2019 Oct 28.
Source
.
Similar
articles
|
|
|
|
Leuva H, Sigel K, Zhou M, Wilkerson J, Aggen DH, Park YA, Anderson
CB, Hsu TM, Langhoff E, McWilliams G, Drake CG, Simon R, Bates SE,
Fojo T.
A novel approach to assess real-world efficacy of
cancer therapy in metastatic prostate cancer. Analysis of national
data on Veterans treated with abiraterone and enzalutamide.
Semin Oncol. 2019 Aug - Oct;46(4-5):351-361. doi:
10.1053/j.seminoncol.2019.11.004. Epub 2019 Nov 16.
Source
.
Similar
articles
|
|
|
|
Malinowski B, Wiciński M, Musiała N, Osowska I, Szostak
M.
Previous, Current, and Future Pharmacotherapy and
Diagnosis of Prostate Cancer-A Comprehensive Review.
Diagnostics (Basel). 2019 Oct 25;9(4). pii: E161. doi:
10.3390/diagnostics9040161.
Source
.
Similar
articles
|
|
|
|
Maurer T, Graefen M, van der Poel H, Hamdy F, Briganti A, Eiber M,
Wester HJ, van Leeuwen FWB.
Prostate-Specific Membrane
Antigen-Guided Surgery.
J Nucl Med. 2020 Jan;61(1):6-12.
doi: 10.2967/jnumed.119.232330. Epub 2019 Nov 15.
Source
.
Similar
articles
|
|
|
|
Morris MJ, Corey E, Guise TA, Gulley JL, Kevin Kelly W, Quinn DI,
Scholz A, Sgouros G.
Radium-223 mechanism of action:
implications for use in treatment combinations.
Nat Rev
Urol. 2019 Dec;16(12):745-756. doi: 10.1038/s41585-019-0251-x.
Epub 2019 Nov 11.
Source
.
Similar
articles
|
|
|
|
Otter SJ, Stewart AJ, Devlin PM.
Modern Brachytherapy.
Hematol Oncol Clin North Am. 2019 Dec;33(6):1011-1025. doi:
10.1016/j.hoc.2019.08.011. Epub 2019 Oct 1.
Source
.
Similar
articles
|
|
|
|
Roviello G, Sobhani N, Corona SP, D'Angelo A.
Corticosteroid
switch after progression on abiraterone acetate plus prednisone.
Int J Clin Oncol. 2019 Nov 8. doi:
10.1007/s10147-019-01577-w. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
|
Ruigrok EAM, van Weerden WM, Nonnekens J, de Jong M.
The
Future of PSMA-Targeted Radionuclide Therapy: An Overview of
Recent Preclinical Research.
Pharmaceutics. 2019 Oct
29;11(11). pii: E560. doi: 10.3390/pharmaceutics11110560.
Source
.
Similar
articles
|
|
|
|
Sathianathen NJ, Koschel S, Thangasamy IA, Teh J, Alghazo O,
Butcher G, Howard H, Kapoor J, Lawrentschuk N, Siva S, Azad A,
Tran B, Bolton D, Murphy DG.
Indirect Comparisons of
Efficacy between Combination Approaches in Metastatic
Hormone-sensitive Prostate Cancer: A Systematic Review and Network
Meta-analysis.
Eur Urol. 2019 Oct 31. pii:
S0302-2838(19)30693-1. doi: 10.1016/j.eururo.2019.09.004. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
|
Student S, Hejmo T, Poterała-Hejmo A, Leśniak A, Bułdak
R.
Anti-androgen hormonal therapy for cancer and other
diseases.
Eur J Pharmacol. 2020 Jan 5;866:172783. doi:
10.1016/j.ejphar.2019.172783. Epub 2019 Nov 8.
Source
.
Similar
articles
|
|
|
|
Tran PT, Ost P.
Developments in oligometastatic
hormone-sensitive prostate cancer.
World J Urol. 2019
Dec;37(12):2545-2547. doi: 10.1007/s00345-019-03009-w. Epub 2019
Nov 9.
Source
.
Similar
articles
|
|
|
|
Zheng X, Zhao X, Xu H, Han X, Xu H, Dong X, Peng R, Yang L, Wei Q,
Ai J.
Efficacy and safety of abiraterone and enzalutamide
for castration-resistant prostate cancer: A systematic review and
meta-analysis of randomized controlled trials.
Medicine
(Baltimore). 2019 Nov;98(44):e17748. doi:
10.1097/MD.0000000000017748.
Source
.
Similar
articles
|
|
|
bottom
|
▲
|
|
|
